COMMONWEALTH EQUITY SERVICES, LLC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$336
+5.0%
66,578
+4.8%
0.00%0.0%
Q2 2023$320
-14.7%
63,553
+4.1%
0.00%0.0%
Q1 2023$375
-53.4%
61,050
+0.1%
0.00%
-50.0%
Q4 2022$805
-99.6%
61,000
+0.2%
0.00%
Q3 2022$180,000
-15.5%
60,900
+4.2%
0.00%
-100.0%
Q2 2022$213,000
-35.5%
58,460
+9.5%
0.00%0.0%
Q1 2022$330,000
-16.9%
53,375
+8.8%
0.00%0.0%
Q4 2021$397,000
+65.4%
49,075
+204.4%
0.00%0.0%
Q3 2021$240,00016,1200.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders